112 related articles for article (PubMed ID: 30769084)
21. A novel in-frame mutation in
Sher M; Farooq M; Abdullah U; Ali Z; Faryal S; Zakaria M; Ullah F; Bukhari H; Møller RS; Tommerup N; Baig SM
Int J Neurosci; 2019 Sep; 129(9):890-895. PubMed ID: 30892110
[No Abstract] [Full Text] [Related]
22. Using Patient-Specific Induced Pluripotent Stem Cells and Wild-Type Mice to Develop a Gene Augmentation-Based Strategy to Treat CLN3-Associated Retinal Degeneration.
Wiley LA; Burnight ER; Drack AV; Banach BB; Ochoa D; Cranston CM; Madumba RA; East JS; Mullins RF; Stone EM; Tucker BA
Hum Gene Ther; 2016 Oct; 27(10):835-846. PubMed ID: 27400765
[TBL] [Abstract][Full Text] [Related]
23. Multifocal retinopathy in Dachshunds with CLN2 neuronal ceroid lipofuscinosis.
Whiting RE; Pearce JW; Castaner LJ; Jensen CA; Katz RJ; Gilliam DH; Katz ML
Exp Eye Res; 2015 May; 134():123-32. PubMed ID: 25697710
[TBL] [Abstract][Full Text] [Related]
24. Histopathologic and immunocytochemical analysis of the retina and ocular tissues in Batten disease.
Bensaoula T; Shibuya H; Katz ML; Smith JE; Johnson GS; John SK; Milam AH
Ophthalmology; 2000 Sep; 107(9):1746-53. PubMed ID: 10964839
[TBL] [Abstract][Full Text] [Related]
25. Gene symbol: CLN3. Disease: Juvenile neuronal ceroid lipofuscinosis (Batten disease).
Leman AR; Pearce DA; Rothberg PG
Hum Genet; 2005 May; 116(6):544. PubMed ID: 15991331
[No Abstract] [Full Text] [Related]
26. Gene symbol: CLN3. Disease: juvenile neuronal ceroid lipofuscinosis (Batten disease).
Leman AR; Pearce DA; Rothberg PG
Hum Genet; 2005 Feb; 116(3):236. PubMed ID: 15818814
[No Abstract] [Full Text] [Related]
27. Strategy for mutation detection in CLN3: characterisation of two Finnish mutations.
Munroe PB; O'Rawe AM; Mitchison HM; Järvelä IE; Santavuori P; Lerner TJ; Taschner PE; Gardiner RM; Mole SE
Neuropediatrics; 1997 Feb; 28(1):15-7. PubMed ID: 9151312
[TBL] [Abstract][Full Text] [Related]
28. Full-field ERG in patients with Batten/Spielmeyer-Vogt disease caused by mutations in the CLN3 gene.
Eksandh LB; Ponjavic VB; Munroe PB; Eiberg HE; Uvebrant PE; Ehinger BE; Mole SE; Andréasson S
Ophthalmic Genet; 2000 Jun; 21(2):69-77. PubMed ID: 10916181
[TBL] [Abstract][Full Text] [Related]
29. Recognizing differentiating clinical signs of CLN3 disease (Batten disease) at presentation.
Kuper WFE; Talsma HE; van Schooneveld MJ; Pott JWR; Huijgen BCH; de Wit GC; van Hasselt PM; van Genderen MM
Acta Ophthalmol; 2021 Jun; 99(4):397-404. PubMed ID: 33073538
[TBL] [Abstract][Full Text] [Related]
30. Autophagic vacuolar myopathy caused by a CLN3 mutation. A case report.
Moro F; Rubegni A; Pochiero F; Mero S; Procopio E; Baldacci J; Donati MA; Santorelli FM
Neuromuscul Disord; 2019 Jan; 29(1):67-69. PubMed ID: 30553701
[TBL] [Abstract][Full Text] [Related]
31. Regional brain atrophy in mouse models of neuronal ceroid lipofuscinosis: a new rostrocaudal perspective.
Kühl TG; Dihanich S; Wong AM; Cooper JD
J Child Neurol; 2013 Sep; 28(9):1117-22. PubMed ID: 24014506
[TBL] [Abstract][Full Text] [Related]
32. [Juvenile neuronal ceroid lipofuscinosis (Batten-Mayou) disease. Ophthalmologic diagnosis and findings].
Seeliger M; Rüther K; Apfelstedt-Sylla E; Schlote W; Wohlrab M; Zrenner E
Ophthalmologe; 1997 Aug; 94(8):557-62. PubMed ID: 9376693
[TBL] [Abstract][Full Text] [Related]
33. Reevaluation of neuronal ceroid lipofuscinoses: atypical juvenile onset may be the result of CLN2 mutations.
Wisniewski KE; Kaczmarski A; Kida E; Connell F; Kaczmarski W; Michalewski MP; Moroziewicz DN; Zhong N
Mol Genet Metab; 1999 Apr; 66(4):248-52. PubMed ID: 10191110
[TBL] [Abstract][Full Text] [Related]
34. Retinal degeneration in motor neuron degeneration: a mouse model of ceroid lipofuscinosis.
Chang B; Bronson RT; Hawes NL; Roderick TH; Peng C; Hageman GS; Heckenlively JR
Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1071-6. PubMed ID: 8125718
[TBL] [Abstract][Full Text] [Related]
35. Novel homozygous CLN3 missense variant in isolated retinal dystrophy: A case report and electron microscopic findings.
Mizobuchi K; Hayashi T; Yoshitake K; Fujinami K; Tachibana T; Tsunoda K; Iwata T; Nakano T
Mol Genet Genomic Med; 2020 Aug; 8(8):e1308. PubMed ID: 32441891
[TBL] [Abstract][Full Text] [Related]
36. Juvenile neuronal ceroid lipofuscinoses.
Wang S
Adv Exp Med Biol; 2012; 724():138-42. PubMed ID: 22411240
[TBL] [Abstract][Full Text] [Related]
37. Sialoadhesin promotes neuroinflammation-related disease progression in two mouse models of CLN disease.
Groh J; Ribechini E; Stadler D; Schilling T; Lutz MB; Martini R
Glia; 2016 May; 64(5):792-809. PubMed ID: 26775238
[TBL] [Abstract][Full Text] [Related]
38. Retinal pigment epithelial dysfunction in early ovine ceroid lipofuscinosis: electrophysiologic and pathologic correlates.
Samuelson D; Dawson WW; Webb AI; Dowson J; Jolly R; Armstrong D
Ophthalmologica; 1985; 190(3):150-7. PubMed ID: 4039810
[TBL] [Abstract][Full Text] [Related]
39. Adult type of neuronal ceroid-lipofuscinosis with retinal involvement.
Ikeda K; Kosaka K; Oyanagi S; Yamada K
Clin Neuropathol; 1984; 3(6):237-9. PubMed ID: 6518685
[TBL] [Abstract][Full Text] [Related]
40. Intravitreal implantation of TPP1-transduced stem cells delays retinal degeneration in canine CLN2 neuronal ceroid lipofuscinosis.
Tracy CJ; Whiting RE; Pearce JW; Williamson BG; Vansteenkiste DP; Gillespie LE; Castaner LJ; Bryan JN; Coates JR; Jensen CA; Katz ML
Exp Eye Res; 2016 Nov; 152():77-87. PubMed ID: 27637672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
